Home › Calculator › COYA Dividend Calculator 2026
COYA Dividend DRIP Calculator 2026
34.13% YieldHealthcareCoya Therapeutics, Inc. · NASDAQ
Price: $5.86 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When COYA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your COYA snowball 📈
$10,000 in COYA → $188.5K in 10 years · $3,996.46/month
About Coya Therapeutics, Inc. (COYA) — Dividend Analysis 2026
Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipeline leverages diverse approaches, including biologics designed to enhance Treg activity, Treg-derived exosomes, and personalized autologous Treg cell therapies. Among its lead candidates is COYA 101, an autologous regulatory T-cell product that has successfully completed Phase 2a clinical trials for treating Amyotrophic Lateral Sclerosis (ALS). Moving towards Investigational New Drug (IND) applications are two key candidates: COYA 301 and COYA 302. COYA 301 is a Treg-enhancing biologic aimed at treating Frontotemporal Dementia. Meanwhile, COYA 302 is a dual-action biologic combination, suitable for subcutaneous or intravenous delivery, engineered to not only boost Treg function but also to diminish harmful T effector cell activity and activated macrophages in neurodegenerative and autoimmune disorders. Additionally, Coya has earlier-stage programs, including COYA 201, an allogeneic (off-the-shelf) Treg exosome candidate in preclinical development for a range of neurodegenerative, autoimmune, and metabolic conditions. Its pipeline also features COYA 206, an antigen-directed Treg-derived exosome product, currently in the discovery phase. Established in 2020, Coya Therapeutics maintains its headquarters in Houston, Texas.
Compare COYA with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full COYA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open COYA position with:
🌍 COYA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold COYA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 34.13% | 31.33% | $3,413 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 29.01% | 26.21% | $2,901 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 27.30% | 24.50% | $2,730 / yr |
| 🇬🇧 UK ISA | 0% | 34.13% | 31.33% | $3,413 / yr |
| 🇬🇧 UK Taxable | 8.75% | 31.14% | 28.34% | $3,114 / yr |
| 🇨🇦 TFSA | 0% | 34.13% | 31.33% | $3,413 / yr |
| 🇨🇦 CA Taxable | 25% | 25.60% | 22.80% | $2,560 / yr |
| 🇦🇺 Super (pension) | 15% | 29.01% | 26.21% | $2,901 / yr |
| 🇦🇺 AU Taxable | 30% | 23.89% | 21.09% | $2,389 / yr |
| 🇩🇪 DE Taxable | 26.375% | 25.13% | 22.33% | $2,513 / yr |
| 🇫🇷 FR Taxable | 30% | 23.89% | 21.09% | $2,389 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 COYA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 COYA Dividend Payment Schedule
COYA pays quarterly — 4 times per year. Next ex-div: TBD.
📊 COYA vs Healthcare Benchmarks
How COYA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for COYA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ COYA Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-04-09 | 10,000 | $4.53 | $45.3K | ||
| A-Award | 2026-01-22 | 140,041 | $4.73 | $662.4K | ||
| A-Award | 2026-01-22 | 140,041 | $4.73 | $662.4K | ||
| A-Award | 2026-01-22 | 15,257 | $4.73 | $72.2K | ||
| A-Award | 2026-01-22 | 293,983 | $4.73 | $1.39M | ||
| A-Award | 2026-01-02 | 10,000 | $5.65 | $56.5K | ||
| A-Award | 2026-01-02 | 10,000 | $5.65 | $56.5K | ||
| A-Award | 2026-01-02 | 10,000 | $5.65 | $56.5K | ||
| A-Award | 2026-01-02 | 10,000 | $5.65 | $56.5K | ||
| A-Award | 2026-01-02 | 10,000 | $5.65 | $56.5K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the COYA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Coya Therapeutics, Inc. (COYA) is currently trading at $5.86, 41% below its 52-week high. The current dividend yield is 34.13% based on an annual payout of $2.00 per share.
COYA (Coya Therapeutics, Inc.) — 34.13% Dividend Yield Analysis
Coya Therapeutics, Inc. (COYA) is a healthcare stock currently trading at $5.86 with a dividend yield of 34.13%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (34.13%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.